Casual Dining’s Comeback: Why Sit-Down Chains Are Beating Fast Casual
Affordable deals and smart upgrades are drawing value-seeking consumers back to the table As inflation pressures household budgets and economic ...
Tag: Growth
Intel Seeks More Equity Infusions Amid Mounting Financial Strains
Talks with new investors follow SoftBank’s $2 billion stake as pressure builds on turnaround plan Intel (INTC) is in discussions ...
Viking Therapeutics Shares Plunge After High Dropout Rate in Weight-Loss Pill Trial
Strong weight reduction overshadowed by concerns over side effects Viking Therapeutics (VKTX) shares plummeted nearly 45% on Tuesday after the ...
Intel Shares Surge After $2 Billion SoftBank Investment
Japanese conglomerate’s backing boosts confidence in chipmaker’s turnaround efforts Intel (INTC) shares jumped more than 9% on Tuesday after SoftBank ...
Strategy Expands Bitcoin Holdings With $51 Million Purchase
Company’s position nears $77 billion valuation amid market swings A U.S. Securities and Exchange Commission filing on Monday revealed that ...
Amphenol Expands Defense Portfolio With $1 Billion Trexon Acquisition
Electronics giant strengthens military and high-tech offerings amid surge in global defense spending Amphenol Corp. (APH) announced Monday that it ...
Buffett Bet Sends UnitedHealth Shares Soaring
Berkshire Hathaway’s stake offers lifeline to embattled insurer amid mounting challenges UnitedHealth Group (UNH) shares surged Friday, notching their best ...
KULR Technology Group Reports Record Q2 Revenue and Expands Bitcoin Treasury Holdings
Frontier technology firm posts strong top-line growth, boosts BTC portfolio, and advances R&D in energy systems and robotics KULR Technology ...
Berkshire Hathaway Adds New Stakes Across Healthcare, Industrials, and Real Estate
Warren Buffett’s conglomerate discloses positions in UnitedHealth, Nucor, D.R. Horton, Lamar Advertising, and Allegion Berkshire Hathaway (BRK.A, BRK.B) has revealed ...
Eli Lilly Strikes $1.3 Billion Deal with Superluminal Medicines to Advance AI-Driven Obesity Drug Development
Partnership leverages artificial intelligence to accelerate discovery of next-generation treatments for obesity and cardiometabolic diseases Eli Lilly (LLY) has entered ...
